CS151744B1 - - Google Patents

Info

Publication number
CS151744B1
CS151744B1 CS357A CS35771A CS151744B1 CS 151744 B1 CS151744 B1 CS 151744B1 CS 357 A CS357 A CS 357A CS 35771 A CS35771 A CS 35771A CS 151744 B1 CS151744 B1 CS 151744B1
Authority
CS
Czechoslovakia
Application number
CS357A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CS357A priority Critical patent/CS151744B1/cs
Publication of CS151744B1 publication Critical patent/CS151744B1/cs

Links

CS357A 1971-01-19 1971-01-19 CS151744B1 (cg-RX-API-DMAC10.html)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS357A CS151744B1 (cg-RX-API-DMAC10.html) 1971-01-19 1971-01-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS357A CS151744B1 (cg-RX-API-DMAC10.html) 1971-01-19 1971-01-19

Publications (1)

Publication Number Publication Date
CS151744B1 true CS151744B1 (cg-RX-API-DMAC10.html) 1973-11-19

Family

ID=5335504

Family Applications (1)

Application Number Title Priority Date Filing Date
CS357A CS151744B1 (cg-RX-API-DMAC10.html) 1971-01-19 1971-01-19

Country Status (1)

Country Link
CS (1) CS151744B1 (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074748A1 (en) 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
WO2002074750A1 (en) * 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
US7482372B2 (en) 2001-05-25 2009-01-27 Bristol-Myers Squibb Company Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074748A1 (en) 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
WO2002074750A1 (en) * 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
EP1676846A2 (en) 2001-03-15 2006-07-05 AstraZeneca AB Hydantoin derivatives as MMP inhibitors
RU2285695C2 (ru) * 2001-03-15 2006-10-20 Астразенека Аб Производные имидазолидин-2,4-диона, содержащие их фармацевтические композиции и их применение
US7482372B2 (en) 2001-05-25 2009-01-27 Bristol-Myers Squibb Company Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Similar Documents

Publication Publication Date Title
FR2120564A5 (cg-RX-API-DMAC10.html)
CS171170B2 (cg-RX-API-DMAC10.html)
FR2122543A1 (cg-RX-API-DMAC10.html)
FR2121862B1 (cg-RX-API-DMAC10.html)
FI52490B (cg-RX-API-DMAC10.html)
FI50489B (cg-RX-API-DMAC10.html)
DK52675A (cg-RX-API-DMAC10.html)
DE2143434C3 (cg-RX-API-DMAC10.html)
FR2125674A5 (cg-RX-API-DMAC10.html)
FR2125166B1 (cg-RX-API-DMAC10.html)
FR2123754A5 (cg-RX-API-DMAC10.html)
FR2125199A1 (cg-RX-API-DMAC10.html)
FR2125686A5 (cg-RX-API-DMAC10.html)
FR2101530A5 (cg-RX-API-DMAC10.html)
CS174315B1 (cg-RX-API-DMAC10.html)
CS151751B1 (cg-RX-API-DMAC10.html)
FI47705B (cg-RX-API-DMAC10.html)
DE2142477C3 (cg-RX-API-DMAC10.html)
CS151286B1 (cg-RX-API-DMAC10.html)
CS165014B1 (cg-RX-API-DMAC10.html)
CS176379B1 (cg-RX-API-DMAC10.html)
FR2121466A3 (cg-RX-API-DMAC10.html)
DE2145668B2 (cg-RX-API-DMAC10.html)
CH563610A (cg-RX-API-DMAC10.html)
BG16707A1 (cg-RX-API-DMAC10.html)